Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Researchers uncover another potential platform for deep brain stimulation, treating patients with chronic and treatment-resistant anorexia.
In this episode we discuss new medical device tax discussions in Washington D.C., the FDA’s investigation into Intuitive Surgical, minor hiccups in Medtronic’s (NYSE:MDT) CoreValve clinical trial, Boston Scientific’s (NYSE:BSX) upcoming Watchman trial results, treating anorexia patients with deep brain stimulation and how to hack for healthcare.
Boston Scientific has a change of heart, deciding to present all 3 co-primary safety and efficacy endpoints from the PREVAIL clinical trial of its Watchman stroke prevention implant.